PhuturdexDrug Pipeline Intelligence

Phuturdex › Drugs › Prednisolone

Drugs in development · updated 30 October 2026

Prednisolone: clinical trials and development status

Other names and codes: Flo-Pred, Orapred Odt, Pediapred, Omnipred

NLM verified identityApproved in the US (FDA)

As of 30 October 2026 Prednisolone is in 83 active clinical trials (recruiting or ongoing, phases I–III) for 84 diseases. The most advanced phase is III.

83Active trials
IIIMost advanced phase
84Diseases studied

Summary updated every week · data as of 30 October 2026. In Phuturdex you can follow Prednisolone and get an email at every change or safety alert.

Sign in free →

Diseases studied

For each disease: the drug’s most advanced phase and active trials, with the reference trial on ClinicalTrials.gov. Showing 30 of 84 diseases.

DiseaseMost advanced phaseActive trialsReference trial
Diffuse large B-cell lymphomaIII9NCT06717347
Prostatic NeoplasmsIII7NCT06952803
Precursor lymphoblastic lymphoma/leukemiaIII6NCT03007147
Burkitt lymphomaIII5NCT03007147
Follicular lymphomaIII5NCT06091254
Acute biphenotypic leukaemiaIII4NCT03007147
IgA glomerulonephritisIII3NCT05510323
LymphomaII–III3NCT07072585
Allergic bronchopulmonary aspergillosisIII2NCT06174922
CataractIII2NCT03933631
Down syndromeIII2NCT03914625
Hepatic insufficiencyIII2NCT06956482
InflammationIII2NCT06472219
MyocarditisIII2NCT05619653
Precursor B-cell lymphoblastic leukemiaIII2NCT03914625
Precursor T-cell lymphoblastic leukemiaIII2NCT03007147
Urogenital neoplasmIII2NCT05288166
Abortion, HabitualIII1NCT03902912
Alcoholic hepatitisIII1NCT06956482
AsthmaII–III1NCT04227483
Autoimmune hepatitisII–III1NCT06650124
Autoimmune thyroiditisII–III1NCT07571681
Beta thalassemiaIII1NCT07884773
Brain NeoplasmsIII1NCT06471465
Bronchiolitis obliterans syndromeIII1NCT06143891
CardiotoxicityIII1NCT06220032
Castration-resistant prostatic neoplasmIII1NCT07225946
ColitisIII1NCT05947669
Extrinsic allergic alveolitisIII1NCT07210008
GlaucomaIII1NCT03933631

Everything on Prednisolone

In Phuturdex you get every trial with sponsors, countries and dates, development events, FDA and EMA approvals, patents and exclusivities, orphan designations and safety alerts, with PDF and Excel export. Free until 31 March 2027.

Open in Phuturdex →

Source: Phuturdex analysis of ClinicalTrials.gov (U.S. National Library of Medicine), FDA and EMA data, updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III. Diseases are those named by each trial (NLM MeSH terms). The estimated launch, when shown, is a Phuturdex calculation described on the Method page, not official data.

ItalianoFrançaisDeutsch